文献速递脑血管病外科神经重症

替罗非班输注在破裂颅内动脉瘤弹簧圈栓塞中的初步研究

Preliminary Study of Tirofiban Infusion in Coil Embolization of Ruptured Intracranial Aneurysms.
PubMed 文献 · Neurosurgery · 2018-01-01

该回顾性研究纳入2008年12月至2015年1月在本机构接受弹簧圈栓塞的249例破裂颅内动脉瘤,其中28例患者(28个破裂及3个未破裂动脉瘤)在栓塞术中或术后接受静脉替罗非班输注,26例同时经微导管动脉内输注。术中25例检出血栓形成,动脉内替罗非班在10分钟以上经造影控制溶解血栓19例(76%)。随访期发生2例颅内出血并发症(血肿范围增大),另2例其他并发症为血尿和口周出血。作者认为静脉替罗非班单用或联合动脉内替罗非班对急性动脉瘤似有用,但若输注前发现合并血肿应考虑替代方案。

要点

  • 28例患者共28个破裂及3个未破裂动脉瘤在弹簧圈栓塞术中或术后接受静脉替罗非班输注。
  • 术中25例检出血栓形成,动脉内替罗非班在10分钟以上溶解血栓19例(76%)。
  • 随访期2例颅内出血并发症(血肿范围增大),另2例为血尿和口周出血。

核心结论

  • 静脉替罗非班单用或联合动脉内替罗非班用于血栓并发症,似可作为急性动脉瘤的治疗。
  • 若患者在接受替罗非班输注前发现合并血肿,应考虑替罗非班的替代方案。

研究设计与样本

  • 回顾性研究,2008年12月至2015年1月在本机构回顾249例接受弹簧圈栓塞的破裂颅内动脉瘤。
  • 28例患者(28个破裂及3个未破裂动脉瘤)在弹簧圈栓塞术中或术后接受静脉替罗非班输注,其中26例同时经微导管动脉内输注替罗非班。

主要发现

  • 术中25例检出血栓形成。
  • 动脉内替罗非班在10分钟以上经造影控制溶解血栓19例(76%)。
  • 随访期发生2例颅内出血并发症(血肿范围增大)。
  • 另发生2例其他并发症:血尿和口周出血。

临床怎么用

  • 作者认为静脉替罗非班单用或联合动脉内替罗非班用于血栓并发症,似可作为急性动脉瘤的治疗。
  • 作者认为若患者在替罗非班输注前发现合并血肿,应考虑替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There have been some reports on the use of intra-arterial tirofiban in ruptured intracranial aneurysms, but few studies have reported on the use of 24 h of intravenous tirofiban infusion in patients with subarachnoid hemorrhage. OBJECTIVE: To present our experience with intravenous tirofiban infusion, in the form of a monotherapy as well as in addition to intra-arterial tirofiban, as a prophylactic, and as a rescue management for thrombus in patients who have undergone embolization with coils for ruptured intracranial aneurysms. METHODS: Between December 2008 and January 2015, we retrospectively reviewed 249 ruptured intracranial aneurysms that were treated with coiling at our institutions. A total of 28 patients harboring 28 ruptured and 3 unruptured intracranial aneurysms underwent intravenous tirofiban infusion during or after coil embolization of an aneurysm. Intra-arterial infusion of tirofiban via a microcatheter was also performed in 26 patients. RESULTS: Thromboembolic formation during the procedure was detected in 25 cases. Intra-arterial tirofiban dissolved the thromboembolus under angiographic control after 10 or more minutes in 19 (76%) of 25 patients. Two intracranial hemorrhagic complications (increase in the extent of hematoma) occurred during the follow-up period. Two cases of other complications occurred: hematuria and perioral bleeding. CONCLUSION: Intravenous tirofiban, as a monotherapy or in addition to intra-arterial tirofiban for thrombotic complications, seems to be useful as a treatment for acute aneurysm. However, alternatives to tirofiban should be considered if an associated hematoma is discovered before a patient receives a tirofiban infusion.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Yoon CH, Lee HW, Kim YS, et al. Preliminary Study of Tirofiban Infusion in Coil Embolization of Ruptured Intracranial Aneurysms. Neurosurgery. 2018. PMID: 28419294. doi:10.1093/neuros/nyx177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。